BusinessChromaDex and Watsons Expand Partnership with TRU NIAGEN™ Retail Launch in SingaporeBy Nasdaq OMXJan 8, 2018, 11:30 AM UTC
BusinessFood Values, Technological Innovations, Savvy Consumers Will Power Major U.S. Food and Nutrition Trends To Watch in 2018By Nasdaq OMXJan 3, 2018, 6:30 PM UTC
BusinessPublished Study Reveals NIAGEN® Nicotinamide Riboside is an Effective NAD Precursor to Protect Cardiac Function in an Animal Model of Heart FailureBy Nasdaq OMXDec 14, 2017, 11:30 AM UTC
BusinessCV Sciences, Inc. to Exhibit at the 25th Annual World Congress on Anti-Aging Medicine in Las Vegas, NV - December 14-16th, 2017By Nasdaq OMXDec 12, 2017, 1:45 PM UTC
BusinessNicotinamide Riboside Shown to Improve Mitochondrial Energy Production and Memory in Alzheimer’s Disease ResearchBy Nasdaq OMXDec 8, 2017, 11:30 AM UTC
BusinessSCU Launches Forward-Looking Programs for Healthcare ProfessionalsBy Nasdaq OMXDec 5, 2017, 1:01 PM UTC
BusinessThe promoting mechanism of TRU NIAGEN™ to be featured at the American Academy of Anti-Aging Medicine World CongressBy Nasdaq OMXDec 4, 2017, 11:30 AM UTC
